<DOC>
	<DOCNO>NCT01979601</DOCNO>
	<brief_summary>This study design measure effect LGT209 give intravenously patient high cholesterol stable dos statin medication , healthy subject elevate cholesterol</brief_summary>
	<brief_title>Safety , Tolerability , PK PD LGT209 Healthy Volunteers Patients With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Healthy volunteer : Male female subject 18 70 year age , general good health high cholesterol Statin patient : Male female patient 18 70 year age , high cholesterol stable statin therapy least 3 month Healthy volunteer : History hypersensitivity study drug drug similar chemical class Women childbearing potential unless use highly effective method contraception Statin patient : Use prescription drug lipid lower HMG COA reductase inhibitor ( statin ) ; use two concurrent antihypertensive medication allow , provide stable dosing achieve prior 3 month Women childbearing potential unless use highly effective method contraception Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>hypercholesterolemia ,</keyword>
	<keyword>LGT209 ,</keyword>
	<keyword>PCSK9 ,</keyword>
	<keyword>LDL-C</keyword>
</DOC>